BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12447900)

  • 1. Reductionism and the search for structure-function relationships in antibody molecules.
    Van Regenmortel MH
    J Mol Recognit; 2002; 15(5):240-7. PubMed ID: 12447900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two and three-dimensional pattern recognition of organized surfaces by specific antibodies.
    Addadi L; Rubin N; Scheffer L; Ziblat R
    Acc Chem Res; 2008 Feb; 41(2):254-64. PubMed ID: 18217721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenicity and immunogenicity of synthetic peptides.
    Van Regenmortel MH
    Biologicals; 2001; 29(3-4):209-13. PubMed ID: 11851317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the structural correlates of affinity maturation: antibody affinity as a function of chemical interactions, structural plasticity and stability.
    David MP; Asprer JJ; Ibana JS; Concepcion GP; Padlan EA
    Mol Immunol; 2007 Feb; 44(6):1342-51. PubMed ID: 16854467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering antibodies for clinical applications.
    Jain M; Kamal N; Batra SK
    Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody modeling: implications for engineering and design.
    Morea V; Lesk AM; Tramontano A
    Methods; 2000 Mar; 20(3):267-79. PubMed ID: 10694450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intracellular antibody capture technology: towards the high-throughput selection of functional intracellular antibodies for target validation.
    Visintin M; Quondam M; Cattaneo A
    Methods; 2004 Oct; 34(2):200-14. PubMed ID: 15312673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Foundations of the new phylogenetics].
    Pavlinov IIa
    Zh Obshch Biol; 2004; 65(4):334-66. PubMed ID: 15490579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of computer-assisted molecular modeling for immunoassay of low molecular weight food contaminants: A review.
    Xu ZL; Shen YD; Beier RC; Yang JY; Lei HT; Wang H; Sun YM
    Anal Chim Acta; 2009 Aug; 647(2):125-36. PubMed ID: 19591697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-combining sites: prediction and design.
    Gregory DS; Staunton D; Martin AC; Cheetham JC; Pedersen J; Rees AR
    Biochem Soc Symp; 1990; 57():147-55. PubMed ID: 2099739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code.
    Fellouse FA; Barthelemy PA; Kelley RF; Sidhu SS
    J Mol Biol; 2006 Mar; 357(1):100-14. PubMed ID: 16413576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic antibodies: structure and function.
    Wentworth P; Janda KD
    Cell Biochem Biophys; 2001; 35(1):63-87. PubMed ID: 11898856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A data integration approach for cell cycle analysis oriented to model simulation in systems biology.
    Alfieri R; Merelli I; Mosca E; Milanesi L
    BMC Syst Biol; 2007 Aug; 1():35. PubMed ID: 17678529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls of reductionism in the design of peptide-based vaccines.
    Van Regenmortel MH
    Vaccine; 2001 Mar; 19(17-19):2369-74. PubMed ID: 11257362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the affinity of antigens for mutated antibodies by use of statistical molecular design.
    Mandrika I; Prusis P; Bergström J; Yahorava S; Wikberg JE
    J Pept Sci; 2008 Jul; 14(7):786-96. PubMed ID: 18200617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.